Ads
related to: small cell lung cancer survival rate- Patient Assistance Tool
Find Financial Support Options
For A NTRK+ Gene Fusion Cancer.
- Resources & Support
Access Helpful Info & More For A
NTRK+ Gene Fusion Cancer Treatment.
- NTRK+ Gene Fusion Testing
Find More Info About Testing For
The NTRK+ Gene.
- Important Safety Info
See Full Safety And
Prescribing Information Here.
- Patient Assistance Tool
Search results
Study shows ivonescimab improves progression-free survival in EGFR+ lung cancer
Medical Xpress· 3 hours agoFor patients with non-small cell lung cancer with the epidermal growth factor receptor (EGFR)...
New lung cancer pill could ‘stop disease in its tracks’
Daily Telegraph· 6 days agoPatients with an incurable form of lung cancer could lead normal lives by taking a daily pill that...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 5 days agoThe results showed a 12-month overall survival (“OS”) rate of 69%, a median overall survival (“mOS”) of 17.5 months, and a 30% overall ...
AstraZeneca Buy rating, stock target reiterated on consistent presence By Investing.com
Investing.com· 1 day agoThe company's trials include AVANZAR, evaluating Dato-DXd plus Imfinzi for first-line treatment of...
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 4 days agoMore patients can fend off the disease for months or years with targeted or immune-boosting drugs,...
RYBREVANT® (amivantamab-vmjw) plus lazertinib is the only chemotherapy-free regimen showing longer...
Valley City Times Record· 6 days agoResults from the new analysis show the RYBREVANT® combination consistently and significantly improved progression-free survival (PFS) compared to osimertinib in patients with ...
Phase III trial shows lorlatinib highly effective against ALK-positive non–small cell lung cancer
Medical Xpress· 2 days agoA large team of medical researchers and doctors has found via phase III clinical trial that the ALK inhibitor lorlatinib is highly effective for treating non–small
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga via Yahoo Finance· 3 days agoMonday, Moderna Inc (NASDAQ:MRNA) and Merck & Co Inc (NYSE:MRK) announced the first presentation of...
Pfizer's drug for advanced lung cancer shows promising long-term trial results
CNBC· 6 days agoThe company's medicine helped patients live longer without seeing their cancer progress, and most...
Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference
Forbes· 22 hours agoThe clinical trial happened in China, meaning that a U.S.-based study will likely be required by the...
Ads
related to: small cell lung cancer survival rate